These results suggest the efficacy of gemcitabine/Tff1 treatment for pancreatic cancer, not only in the implantation model but also in the spontaneous cancer‐developing model in which the tumor microenvironment is preserved. The gene discussed is TFF1; the disease is familial pancreatic carcinoma.